Dr. Jay Shrestha focuses on inter partes reviews and patent prosecution. He has experience with pharmaceuticals, medical devices, targeted drug delivery, pathology specimen processing, gene therapy, cancer biology, antibodies, immunotherapy, vaccines, RNA interference, transgenic crops, vegetable varieties, food processing, biopolymers, biofuels, electrical devices, material sciences, mechanical arts, and other technologies. He also focuses on emerging technologies such as blockchain and e-sports, and emerging industries such as legalized cannabis.

Prior to joining Zuber Lawler, Dr. Shrestha practiced at Pillsbury Winthrop Shaw Pittman LLP​.

Panels & Speaking Engagements

  • Mol Plant Microbe Interact. 2017 Feb; 30(2): 150-160
  • Plant Cell. 2014 Oct; 26(10): 4171-87
  • Mol Plant. 2014 Aug; 7(8): 1365–1383
  • Plant Physiol. 2011 Oct; 157(2): 947–970
  • Plant Physiol. 2009 Oct; 151(2): 574–589
  • Nucleic Acids Res. 2005; 33(16): 5362–5370